Page 46 - Read Online

Page 10 of 10 Boshe et al. J Transl Genet Genom 2018;2:12. I https://doi.org/10.20517/jtgg.2018.18

17. Vatta M, Ackerman MJ, Ye B, Makielski JC, Ughanze EE, Taylor EW, Tester DJ, Balijepalli RC, Foell JD, Li Z, Kamp TJ, Towbin JA. Mu-
tant Caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 2006;114:2104-12.
18. Ye B, Tester DJ, Vatta M, Makielski JC, Ackerman MJ. Molecular and functional characterization of novel CAV3-encoded caveolin-3 muta-
tions in congenital long QT syndrome. Heart Rhythm 2006;3:S1.
19. Medeiros-Domingo A, Kaku T, Tester DJ, Iturralde-Torres P, Itty A, Ye B, Valdivia C, Ueda K, Canizales-Quinteros S, Tusié-Luna MT,
Makielski JC, Ackerman MJ. SCN4B-encoded sodium channel 4 subunit in congenital long-QT syndrome. Circulation 2007;116:134-42.
20. Chen L, Marquardt ML, Tester DJ, Sampson KJ, Ackerman MJ, Kass RS. Mutation of an A-kinase-anchoring protein causes long-QT syn-
drome. Proc Natl Acad Sci USA 2007;104:20990-5.
21. Maltese PE, Orlova N, Krasikova E, Emelyanchik E, Cheremisina A, Kuscaeva A, Salmina A, Miotto R, Bonizzato A, Guerri G, Zuntini M,
Nicoulina S, Bertelli M. Gene-targeted analysis of clinically diagnosed long QT Russian families. Int Heart J 2017;58:81-7.
22. Shimizu W. Clinical impact of genetic studies in lethal inherited cardiac arrhythmias. Circ J 2008;72:1926-36.
23. Angrist M, Chandrasekharan S, Heaney C, Cook-Deegan R. Impact of gene patents and licensing practices on access to genetic testing for
long QT syndrome. Genet Med 2010;12:S111-54.
24. Strande NT, Riggs ER, Buchanan AH, Ceyhan-Birsoy O, DiStefano M, Dwight SS, Goldstein J, Ghosh R, Seifert BA, Sneddon TP, Wright
MW, Milko LV, Cherry JM, Giovanni MA, Murray MF, O’Daniel JM, Ramos EM, Santani AB, Scott AF, Plon SE, Rehm HL, Martin CL,
Berg JS. Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the clinical genome re-
source. Am J Hum Genet 2017;100:895-906.
25. National human genome research institute (NHGRI) online resource. Regulation of Genetic Tests. Available from: www.genome.
gov/10002335/regulation-of-genetic-tests/. [Last accessed on 25 Jun 2018]
26. Okur V, Chung WK. The impact of hereditary cancer gene panels on clinical care and lessons learned. Cold Spring Harb Mol Case Stud
2017;3: a002154.
27. Kurian AW, Li Y, Hamilton AS, Ward KC, Hawley ST, Morrow M, McLeod MC, Jagsi R, Katz SJ. Gaps in incorporating germline genetic
testing into treatment decision-making for early-stage breast cancer. J Clin Oncol 2017;35:2232-9.
28. Wooderchak-Donahue W, VanSant-Webb C, Tvrdik T, Plant P, Lewis T, Stocks J, Raney JA, Meyers L, Berg A, Rope AF, Yetman AT, Bleyl
SB, Mesley R, Bull DA, Collins RT, Ojeda MM, Roberts A, Lacro R, Woerner A, Stoler J, Bayrak-Toydemir P. Clinical utility of a next gen-
eration sequencing panel assay for Marfan and Marfan-like syndromes featuring aortopathy. Am J Med Genet A 2015;167A:1747-57.